Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

614 studies match

clinicaltrialsPublishedShowing 401–450 of 614 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00480025	GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer	terminated	Phase 3	2,278	GlaxoSmithKlineINDUSTRY	34	Dec 22, 2020	clinicaltrials
NCT03098030	Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer	completed	Phase 2 / Phase 3	483	United TherapeuticsINDUSTRY	23	Dec 9, 2020	clinicaltrials